Head to Head Survey: Progyny (NASDAQ:PGNY) & Sotera Health (NYSE:SHC)

Progyny (NASDAQ:PGNY) and Sotera Health (NYSE:SHC) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Progyny and Sotera Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Progyny 0 0 6 0 3.00
Sotera Health 0 0 10 0 3.00

Progyny currently has a consensus target price of $38.83, indicating a potential downside of 23.93%. Sotera Health has a consensus target price of $32.75, indicating a potential upside of 31.32%. Given Sotera Health’s higher possible upside, analysts clearly believe Sotera Health is more favorable than Progyny.


This table compares Progyny and Sotera Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Progyny 1.03% 7.43% 5.04%
Sotera Health N/A N/A N/A

Institutional and Insider Ownership

58.5% of Progyny shares are owned by institutional investors. 33.3% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Progyny and Sotera Health’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Progyny $229.68 million 19.39 -$8.57 million $0.11 464.09
Sotera Health N/A N/A N/A N/A N/A

Sotera Health has lower revenue, but higher earnings than Progyny.


Progyny beats Sotera Health on 6 of the 8 factors compared between the two stocks.

About Progyny

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

About Sotera Health

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.